25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Avanos Medical Inc
Buy, Hold or Sell?

Let's analyze Avanos together

I guess you are interested in Avanos Medical Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Avanos Medical Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Avanos Medical Inc

I send you an email if I find something interesting about Avanos Medical Inc.

1. Quick Overview

1.1. Quick analysis of Avanos (30 sec.)










1.2. What can you expect buying and holding a share of Avanos? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
30.0%

What is your share worth?

Current worth
$26.39
Expected worth in 1 year
$26.66
How sure are you?
70.0%

+ What do you gain per year?

Total Gains per Share
$0.28
Return On Investment
1.5%

For what price can you sell your share?

Current Price per Share
$17.97
Expected price per share
$17.24 - $22.04
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Avanos (5 min.)




Live pricePrice per Share (EOD)
$17.97
Intrinsic Value Per Share
$4.67 - $20.32
Total Value Per Share
$31.06 - $46.71

2.2. Growth of Avanos (5 min.)




Is Avanos growing?

Current yearPrevious yearGrowGrow %
How rich?$1.2b$1.2b-$32.7m-2.7%

How much money is Avanos making?

Current yearPrevious yearGrowGrow %
Making money$3.9m-$13.8m$17.7m452.9%
Net Profit Margin2.3%-8.7%--

How much money comes from the company's main activities?

2.3. Financial Health of Avanos (5 min.)




2.4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#31 / 320

Most Revenue
#54 / 320

Most Profit
#70 / 320

Most Efficient
#104 / 320
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Avanos?

Welcome investor! Avanos's management wants to use your money to grow the business. In return you get a share of Avanos.

First you should know what it really means to hold a share of Avanos. And how you can make/lose money.

Speculation

The Price per Share of Avanos is $17.97. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Avanos.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Avanos, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $26.39. Based on the TTM, the Book Value Change Per Share is $0.07 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.19 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Avanos.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.090.5%0.080.5%-0.29-1.6%-0.04-0.2%-0.16-0.9%
Usd Book Value Change Per Share0.000.0%0.070.4%-0.19-1.1%-0.010.0%-0.46-2.5%
Usd Dividend Per Share0.000.0%0.000.0%1.508.4%0.311.7%0.955.3%
Usd Total Gains Per Share0.000.0%0.070.4%1.317.3%0.311.7%0.492.7%
Usd Price Per Share24.03-21.57-25.65-29.33-35.64-
Price to Earnings Ratio65.10--9.36--185.80--38.96--12.30-
Price-to-Total Gains Ratio-5,138.42--1,194.13-20.58--46.24-719.24-
Price to Book Ratio0.91-0.81-0.95-1.11-1.36-
Price-to-Total Gains Ratio-5,138.42--1,194.13-20.58--46.24-719.24-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share17.97
Number of shares55
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.31
Usd Book Value Change Per Share0.07-0.01
Usd Total Gains Per Share0.070.31
Gains per Quarter (55 shares)3.7816.78
Gains per Year (55 shares)15.1367.13
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1015569-257
203020138-4124
304535207-6191
406150276-8258
507665345-9325
609180414-11392
7010695483-13459
80121110552-15526
90136125621-17593
100151140690-19660

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.01.00.075.0%8.04.00.066.7%11.09.00.055.0%26.014.00.065.0%32.016.00.066.7%
Book Value Change Per Share2.02.00.050.0%7.05.00.058.3%10.010.00.050.0%25.015.00.062.5%29.017.02.060.4%
Dividend per Share0.00.04.00.0%5.00.07.041.7%7.00.013.035.0%12.00.028.030.0%12.00.036.025.0%
Total Gains per Share2.02.00.050.0%8.04.00.066.7%12.08.00.060.0%28.012.00.070.0%32.014.02.066.7%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Avanos Medical Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.0050.069-107%-0.192+4015%-0.009+83%-0.458+9687%
Book Value Per Share--26.38826.4720%26.960-2%26.5170%26.319+0%
Current Ratio--2.2202.213+0%2.946-25%2.768-20%2.556-13%
Debt To Asset Ratio--0.2580.263-2%0.270-5%0.264-2%0.334-23%
Debt To Equity Ratio--0.3470.356-3%0.370-6%0.360-4%0.532-35%
Dividend Per Share----0%1.502-100%0.314-100%0.951-100%
Enterprise Value--782298000.000650018500.000+20%836477000.000-6%1060250800.000-26%1199145566.000-35%
Eps--0.0920.084+10%-0.293+417%-0.037+140%-0.160+273%
Ev To Ebitda Ratio--8.0156.832+17%13.669-41%12.272-35%33.194-76%
Ev To Sales Ratio--1.1480.953+20%1.114+3%1.437-20%1.417-19%
Free Cash Flow Per Share--0.4290.197+118%0.195+121%0.157+174%0.083+417%
Free Cash Flow To Equity Per Share--0.086-0.535+724%0.187-54%-0.039+146%-0.176+305%
Gross Profit Margin--1.0001.0000%1.0000%0.797+25%0.898+11%
Intrinsic Value_10Y_max--20.317--------
Intrinsic Value_10Y_min--4.669--------
Intrinsic Value_1Y_max--1.279--------
Intrinsic Value_1Y_min--0.357--------
Intrinsic Value_3Y_max--4.419--------
Intrinsic Value_3Y_min--1.176--------
Intrinsic Value_5Y_max--8.255--------
Intrinsic Value_5Y_min--2.100--------
Market Cap825847290.000-36%1119798000.0001001793500.000+12%1200052000.000-7%1394350800.000-20%1687853066.000-34%
Net Profit Margin--0.0250.023+11%-0.087+445%-0.013+150%-0.027+206%
Operating Margin--0.0750.074+1%0.034+118%0.023+229%0.029+153%
Operating Ratio--0.9020.909-1%0.968-7%0.975-7%0.947-5%
Pb Ratio0.681-34%0.9110.815+12%0.949-4%1.107-18%1.356-33%
Pe Ratio48.686-34%65.105-9.356+114%-185.802+385%-38.965+160%-12.301+119%
Price Per Share17.970-34%24.03021.573+11%25.645-6%29.330-18%35.636-33%
Price To Free Cash Flow Ratio10.468-34%13.99710.987+27%-14.241+202%-28.471+303%-44.665+419%
Price To Total Gains Ratio-3842.588+25%-5138.419-1194.134-77%20.577-25072%-46.244-99%719.244-814%
Quick Ratio--1.0381.016+2%1.508-31%1.558-33%1.448-28%
Return On Assets--0.0030.002+11%-0.008+426%-0.001+146%-0.004+271%
Return On Equity--0.0030.003+10%-0.011+425%-0.002+143%-0.008+338%
Total Gains Per Share---0.0050.069-107%1.310-100%0.305-102%0.493-101%
Usd Book Value--1229700000.0001228975000.000+0%1261700000.000-3%1256935000.000-2%1244415000.000-1%
Usd Book Value Change Per Share---0.0050.069-107%-0.192+4015%-0.009+83%-0.458+9687%
Usd Book Value Per Share--26.38826.4720%26.960-2%26.5170%26.319+0%
Usd Dividend Per Share----0%1.502-100%0.314-100%0.951-100%
Usd Enterprise Value--782298000.000650018500.000+20%836477000.000-6%1060250800.000-26%1199145566.000-35%
Usd Eps--0.0920.084+10%-0.293+417%-0.037+140%-0.160+273%
Usd Free Cash Flow--20000000.0009150000.250+119%9150000.000+119%7430000.050+169%3755000.025+433%
Usd Free Cash Flow Per Share--0.4290.197+118%0.195+121%0.157+174%0.083+417%
Usd Free Cash Flow To Equity Per Share--0.086-0.535+724%0.187-54%-0.039+146%-0.176+305%
Usd Market Cap825847290.000-36%1119798000.0001001793500.000+12%1200052000.000-7%1394350800.000-20%1687853066.000-34%
Usd Price Per Share17.970-34%24.03021.573+11%25.645-6%29.330-18%35.636-33%
Usd Profit--4300000.0003925000.000+10%-13850000.000+422%-1745000.000+141%-8170000.000+290%
Usd Revenue--170400000.000170375000.000+0%187475000.000-9%184155000.000-7%226522500.000-25%
Usd Total Gains Per Share---0.0050.069-107%1.310-100%0.305-102%0.493-101%
 EOD+5 -3MRQTTM+26 -11YOY+18 -215Y+20 -2010Y+22 -18

3.3 Fundamental Score

Let's check the fundamental score of Avanos Medical Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1548.686
Price to Book Ratio (EOD)Between0-10.681
Net Profit Margin (MRQ)Greater than00.025
Operating Margin (MRQ)Greater than00.075
Quick Ratio (MRQ)Greater than11.038
Current Ratio (MRQ)Greater than12.220
Debt to Asset Ratio (MRQ)Less than10.258
Debt to Equity Ratio (MRQ)Less than10.347
Return on Equity (MRQ)Greater than0.150.003
Return on Assets (MRQ)Greater than0.050.003
Total7/10 (70.0%)

3.4 Technical Score

Let's check the technical score of Avanos Medical Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5034.893
Ma 20Greater thanMa 5018.667
Ma 50Greater thanMa 10020.351
Ma 100Greater thanMa 20021.937
OpenGreater thanClose18.340
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Avanos Medical Inc

Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

Fundamental data was last updated by Penke on 2024-12-07 15:56:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Avanos earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Avanos to the Medical Devices industry mean.
  • A Net Profit Margin of 2.5% means that $0.03 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Avanos Medical Inc:

  • The MRQ is 2.5%. The company is making a profit. +1
  • The TTM is 2.3%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ2.5%TTM2.3%+0.3%
TTM2.3%YOY-8.7%+11.0%
TTM2.3%5Y-1.3%+3.5%
5Y-1.3%10Y-2.7%+1.4%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.5%-6.4%+8.9%
TTM2.3%-14.6%+16.9%
YOY-8.7%-16.4%+7.7%
5Y-1.3%-18.0%+16.7%
10Y-2.7%-21.7%+19.0%
4.3.1.2. Return on Assets

Shows how efficient Avanos is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Avanos to the Medical Devices industry mean.
  • 0.3% Return on Assets means that Avanos generated $0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Avanos Medical Inc:

  • The MRQ is 0.3%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.2%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.3%TTM0.2%+0.0%
TTM0.2%YOY-0.8%+1.1%
TTM0.2%5Y-0.1%+0.4%
5Y-0.1%10Y-0.4%+0.3%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3%-2.2%+2.5%
TTM0.2%-3.2%+3.4%
YOY-0.8%-4.1%+3.3%
5Y-0.1%-3.0%+2.9%
10Y-0.4%-4.0%+3.6%
4.3.1.3. Return on Equity

Shows how efficient Avanos is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Avanos to the Medical Devices industry mean.
  • 0.3% Return on Equity means Avanos generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Avanos Medical Inc:

  • The MRQ is 0.3%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 0.3%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.3%TTM0.3%+0.0%
TTM0.3%YOY-1.1%+1.5%
TTM0.3%5Y-0.2%+0.5%
5Y-0.2%10Y-0.8%+0.7%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3%-2.6%+2.9%
TTM0.3%-3.9%+4.2%
YOY-1.1%-4.7%+3.6%
5Y-0.2%-4.0%+3.8%
10Y-0.8%-5.5%+4.7%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Avanos Medical Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Avanos is operating .

  • Measures how much profit Avanos makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Avanos to the Medical Devices industry mean.
  • An Operating Margin of 7.5% means the company generated $0.07  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Avanos Medical Inc:

  • The MRQ is 7.5%. The company is operating less efficient.
  • The TTM is 7.4%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ7.5%TTM7.4%+0.0%
TTM7.4%YOY3.4%+4.0%
TTM7.4%5Y2.3%+5.1%
5Y2.3%10Y2.9%-0.7%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ7.5%-13.1%+20.6%
TTM7.4%-20.2%+27.6%
YOY3.4%-13.7%+17.1%
5Y2.3%-16.5%+18.8%
10Y2.9%-20.9%+23.8%
4.3.2.2. Operating Ratio

Measures how efficient Avanos is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 0.90 means that the operating costs are $0.90 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Avanos Medical Inc:

  • The MRQ is 0.902. The company is less efficient in keeping operating costs low.
  • The TTM is 0.909. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.902TTM0.909-0.007
TTM0.909YOY0.968-0.059
TTM0.9095Y0.975-0.066
5Y0.97510Y0.947+0.028
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9021.213-0.311
TTM0.9091.305-0.396
YOY0.9681.328-0.360
5Y0.9751.366-0.391
10Y0.9471.312-0.365
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Avanos Medical Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Avanos is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 2.22 means the company has $2.22 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Avanos Medical Inc:

  • The MRQ is 2.220. The company is able to pay all its short-term debts. +1
  • The TTM is 2.213. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.220TTM2.213+0.007
TTM2.213YOY2.946-0.733
TTM2.2135Y2.768-0.554
5Y2.76810Y2.556+0.212
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.2202.567-0.347
TTM2.2132.707-0.494
YOY2.9462.888+0.058
5Y2.7683.435-0.667
10Y2.5563.527-0.971
4.4.3.2. Quick Ratio

Measures if Avanos is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Avanos to the Medical Devices industry mean.
  • A Quick Ratio of 1.04 means the company can pay off $1.04 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Avanos Medical Inc:

  • The MRQ is 1.038. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.016. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.038TTM1.016+0.022
TTM1.016YOY1.508-0.492
TTM1.0165Y1.558-0.542
5Y1.55810Y1.448+0.110
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0381.442-0.404
TTM1.0161.678-0.662
YOY1.5081.892-0.384
5Y1.5582.299-0.741
10Y1.4482.555-1.107
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Avanos Medical Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Avanos assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Avanos to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.26 means that Avanos assets are financed with 25.8% credit (debt) and the remaining percentage (100% - 25.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Avanos Medical Inc:

  • The MRQ is 0.258. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.263. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.258TTM0.263-0.005
TTM0.263YOY0.270-0.007
TTM0.2635Y0.264-0.001
5Y0.26410Y0.334-0.070
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2580.401-0.143
TTM0.2630.401-0.138
YOY0.2700.362-0.092
5Y0.2640.431-0.167
10Y0.3340.453-0.119
4.5.4.2. Debt to Equity Ratio

Measures if Avanos is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Avanos to the Medical Devices industry mean.
  • A Debt to Equity ratio of 34.7% means that company has $0.35 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Avanos Medical Inc:

  • The MRQ is 0.347. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.356. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.347TTM0.356-0.010
TTM0.356YOY0.370-0.014
TTM0.3565Y0.360-0.004
5Y0.36010Y0.532-0.172
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3470.565-0.218
TTM0.3560.600-0.244
YOY0.3700.535-0.165
5Y0.3600.635-0.275
10Y0.5320.712-0.180
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Avanos generates.

  • Above 15 is considered overpriced but always compare Avanos to the Medical Devices industry mean.
  • A PE ratio of 65.10 means the investor is paying $65.10 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Avanos Medical Inc:

  • The EOD is 48.686. Based on the earnings, the company is overpriced. -1
  • The MRQ is 65.105. Based on the earnings, the company is expensive. -2
  • The TTM is -9.356. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD48.686MRQ65.105-16.418
MRQ65.105TTM-9.356+74.460
TTM-9.356YOY-185.802+176.446
TTM-9.3565Y-38.965+29.609
5Y-38.96510Y-12.301-26.664
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD48.686-0.983+49.669
MRQ65.105-1.351+66.456
TTM-9.356-1.807-7.549
YOY-185.802-2.342-183.460
5Y-38.965-2.144-36.821
10Y-12.301-1.958-10.343
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Avanos Medical Inc:

  • The EOD is 10.468. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 13.997. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 10.987. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD10.468MRQ13.997-3.530
MRQ13.997TTM10.987+3.010
TTM10.987YOY-14.241+25.228
TTM10.9875Y-28.471+39.458
5Y-28.47110Y-44.665+16.194
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD10.468-1.567+12.035
MRQ13.997-1.910+15.907
TTM10.987-2.233+13.220
YOY-14.241-5.489-8.752
5Y-28.471-4.008-24.463
10Y-44.665-4.828-39.837
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Avanos is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 0.91 means the investor is paying $0.91 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Avanos Medical Inc:

  • The EOD is 0.681. Based on the equity, the company is cheap. +2
  • The MRQ is 0.911. Based on the equity, the company is cheap. +2
  • The TTM is 0.815. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.681MRQ0.911-0.230
MRQ0.911TTM0.815+0.096
TTM0.815YOY0.949-0.134
TTM0.8155Y1.107-0.292
5Y1.10710Y1.356-0.249
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD0.6812.159-1.478
MRQ0.9112.159-1.248
TTM0.8152.344-1.529
YOY0.9493.005-2.056
5Y1.1074.023-2.916
10Y1.3564.497-3.141
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Avanos Medical Inc.

4.8.1. Institutions holding Avanos Medical Inc

Institutions are holding 96.078% of the shares of Avanos Medical Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-06-30BlackRock Inc15.2560.00327011219-248055-3.4171
2024-09-30Vanguard Group Inc11.57670.00235320302501660.9519
2024-09-30RGM Capital LLC6.90093.2995317145500
2024-09-30Dimensional Fund Advisors, Inc.5.63570.01512589985123500.4791
2024-09-30T. Rowe Price Investment Management,Inc.5.15060.034323670451492526.7298
2024-09-30Westwood Holdings Group Inc4.33240.20171991055-93062-4.4653
2024-09-30State Street Corp3.96430.00181821884-2451-0.1344
2024-09-30Brown Advisory Holdings Inc3.7010.05131700876300931.8011
2024-09-30William Blair Investment Management, LLC2.99760.08171377602-42393-2.9854
2024-09-30Paradice Investment Management LLC2.74665.27811262249-82700-6.1489
2024-09-30Morgan Stanley - Brokerage Accounts2.46410.002113244741425157.6794
2024-09-30Neuberger Berman Group LLC2.32130.021066814688416.8981
2024-09-30Geode Capital Management, LLC2.29380.00211054162160651.5475
2024-09-30Tributary Capital Management, LLC1.4071.2066646629-96427-12.9771
2024-09-30Prudential Financial Inc1.27670.0199586730-34840-5.6052
2024-09-30Royal Bank of Canada1.26330.0029580554-7323-1.2457
2024-09-30Charles Schwab Investment Management Inc1.13910.0024523494-44734-7.8725
2024-09-30Northern Trust Corp1.09240.00250204359811.2057
2024-09-30Arrowstreet Capital Limited Partnership0.98990.0093454931357750368.1275
2024-09-30Goldman Sachs Group Inc0.91050.0016418417240463135.1265
Total 77.419910.237835579893+693227+1.9%

4.9.2. Funds holding Avanos Medical Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-11-27iShares Core S&P Small-Cap ETF6.44230.06296067315360.0519
2024-10-31Vanguard Total Stock Mkt Idx Inv3.16680.0016145538221640.1489
2024-09-30T. Rowe Price Small-Cap Value3.01250.3064138444900
2024-11-27iShares Russell 2000 ETF2.69260.02941237461-2590-0.2089
2024-10-31Vanguard Small Cap Index2.51130.0142115410622500.1953
2024-10-31Brown Advisory Small-Cap Fdmtl Val Inv2.21511.32761017974-8934-0.87
2024-09-30Paradice Global Small Mid Cap Strategy1.74322.43148011248011240
2024-10-31Vanguard Small Cap Value Index Inv1.69410.0251778556-268-0.0344
2024-09-30T. Rowe Price U.S. SC Value Eq Tr-Z1.61340.3053741473515327.469
2024-09-30Westwood Mgt SmallCap Value1.54311.4778709156-75489-9.6208
2024-09-30Westwood Quality SmallCap Fund Inst1.54311.4799709156-75489-9.6208
2024-10-31Vanguard Institutional Extnd Mkt Idx Tr1.47680.0117678701-2301-0.3379
2024-09-30DFA US Small Cap Value I1.4660.0967673733109941.6589
2024-10-31Tributary Small Cap Equity1.25071.155657478610169821.4966
2024-10-31William Blair Small Cap Value I1.13760.7725522799-9234-1.7356
2024-11-27iShares S&P Small-Cap 600 Value ETF1.02080.1169469145-1856-0.3941
2024-09-30Fidelity Small Cap Index1.00610.0405462375-1975-0.4253
2024-11-27iShares Russell 2000 Value ETF0.96750.06114446265740.1293
2024-11-27SPDR® Portfolio S&P 600™ Sm Cap ETF0.91580.06054208523080.0732
2024-09-30Tributary Small Company Instl0.81891.1399376330-94082-19.9999
Total 38.237710.914117572857+699962+4.0%

5.3. Insider Transactions

Insiders are holding 2.949% of the shares of Avanos Medical Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-03-14Michael GreinerSELL800019.12
2024-03-11Julie Ann ShimerBUY50019.85
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets1,656,200
Total Liabilities426,500
Total Stockholder Equity1,229,700
 As reported
Total Liabilities 426,500
Total Stockholder Equity+ 1,229,700
Total Assets = 1,656,200

Assets

Total Assets1,656,200
Total Current Assets472,600
Long-term Assets1,183,600
Total Current Assets
Cash And Cash Equivalents 89,000
Net Receivables 131,900
Inventory 161,900
Other Current Assets 89,800
Total Current Assets  (as reported)472,600
Total Current Assets  (calculated)472,600
+/-0
Long-term Assets
Property Plant Equipment 136,000
Goodwill 795,100
Intangible Assets 220,100
Long-term Assets Other 25,800
Long-term Assets  (as reported)1,183,600
Long-term Assets  (calculated)1,177,000
+/- 6,600

Liabilities & Shareholders' Equity

Total Current Liabilities212,900
Long-term Liabilities213,600
Total Stockholder Equity1,229,700
Total Current Liabilities
Short-term Debt 23,100
Short Long Term Debt 9,400
Accounts payable 54,200
Other Current Liabilities 129,400
Total Current Liabilities  (as reported)212,900
Total Current Liabilities  (calculated)216,100
+/- 3,200
Long-term Liabilities
Long term Debt 152,600
Capital Lease Obligations 40,200
Long-term Liabilities Other 3,900
Long-term Liabilities  (as reported)213,600
Long-term Liabilities  (calculated)196,700
+/- 16,900
Total Stockholder Equity
Common Stock500
Retained Earnings -309,700
Accumulated Other Comprehensive Income -36,900
Other Stockholders Equity 1,575,800
Total Stockholder Equity (as reported)1,229,700
Total Stockholder Equity (calculated)1,229,700
+/-0
Other
Capital Stock500
Cash and Short Term Investments 89,000
Common Stock Shares Outstanding 46,600
Current Deferred Revenue96,400
Liabilities and Stockholders Equity 1,656,200
Net Debt 113,200
Net Invested Capital 1,391,700
Net Working Capital 259,700
Property Plant and Equipment Gross 273,200
Short Long Term Debt Total 202,200



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-31
> Total Assets 
2,534,200
0
0
0
2,484,000
2,463,400
2,456,300
2,449,400
2,527,600
2,536,400
2,485,500
2,006,300
2,000,200
2,019,700
2,112,000
2,095,000
2,071,800
2,086,400
2,124,900
2,148,900
2,195,900
2,202,900
1,917,400
1,844,500
1,833,400
1,834,000
1,783,400
1,807,700
1,799,600
1,763,700
1,755,900
1,799,100
1,672,800
1,648,800
1,683,300
1,597,900
1,594,600
1,766,500
1,752,800
1,775,200
1,786,900
1,734,900
1,666,700
1,724,900
1,692,400
1,661,300
1,657,800
1,656,200
1,656,2001,657,8001,661,3001,692,4001,724,9001,666,7001,734,9001,786,9001,775,2001,752,8001,766,5001,594,6001,597,9001,683,3001,648,8001,672,8001,799,1001,755,9001,763,7001,799,6001,807,7001,783,4001,834,0001,833,4001,844,5001,917,4002,202,9002,195,9002,148,9002,124,9002,086,4002,071,8002,095,0002,112,0002,019,7002,000,2002,006,3002,485,5002,536,4002,527,6002,449,4002,456,3002,463,4002,484,0000002,534,200
   > Total Current Assets 
0
0
0
0
585,100
571,400
598,300
596,100
684,900
703,100
653,100
666,000
676,000
706,600
609,700
605,600
593,500
614,400
654,800
681,000
1,160,700
1,161,100
876,500
737,200
713,600
660,000
572,500
546,500
538,500
524,100
517,100
567,600
467,200
447,900
443,500
405,000
418,600
439,200
437,100
470,000
499,800
453,800
506,900
524,600
487,000
467,800
474,100
472,600
472,600474,100467,800487,000524,600506,900453,800499,800470,000437,100439,200418,600405,000443,500447,900467,200567,600517,100524,100538,500546,500572,500660,000713,600737,200876,5001,161,1001,160,700681,000654,800614,400593,500605,600609,700706,600676,000666,000653,100703,100684,900596,100598,300571,400585,1000000
       Cash And Cash Equivalents 
47,900
0
0
0
44,100
35,800
48,500
58,400
149,000
166,200
114,300
112,500
129,500
165,100
79,200
86,700
113,700
143,100
154,800
166,100
219,700
203,100
479,600
411,800
384,500
348,300
288,100
214,400
205,300
187,700
185,000
180,000
111,500
100,100
99,900
97,800
118,500
104,300
106,500
117,000
127,700
95,700
81,800
107,100
87,700
75,800
92,200
89,000
89,00092,20075,80087,700107,10081,80095,700127,700117,000106,500104,300118,50097,80099,900100,100111,500180,000185,000187,700205,300214,400288,100348,300384,500411,800479,600203,100219,700166,100154,800143,100113,70086,70079,200165,100129,500112,500114,300166,200149,00058,40048,50035,80044,10000047,900
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
51,500
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000051,5000000000000000000000000
       Net Receivables 
0
0
0
0
203,300
197,900
195,300
192,200
233,900
226,500
200,100
204,400
224,700
206,300
195,200
189,100
190,100
181,200
184,100
194,400
203,000
199,500
189,200
151,800
150,500
135,000
124,300
157,700
163,800
159,600
137,800
182,300
167,900
164,300
165,100
129,100
131,200
161,600
145,400
146,200
167,900
142,700
152,300
145,200
142,800
131,300
123,000
131,900
131,900123,000131,300142,800145,200152,300142,700167,900146,200145,400161,600131,200129,100165,100164,300167,900182,300137,800159,600163,800157,700124,300135,000150,500151,800189,200199,500203,000194,400184,100181,200190,100189,100195,200206,300224,700204,400200,100226,500233,900192,200195,300197,900203,3000000
       Other Current Assets 
60,400
0
0
0
52,100
51,900
53,200
50,800
16,800
17,400
14,800
25,500
18,600
26,800
25,000
31,100
17,200
16,700
19,700
20,000
14,400
15,800
48,400
52,400
57,200
47,100
26,200
29,900
23,500
23,700
20,200
21,200
18,900
18,300
18,800
19,700
18,600
15,700
16,200
13,200
13,900
15,400
15,800
13,600
93,300
95,100
95,000
89,800
89,80095,00095,10093,30013,60015,80015,40013,90013,20016,20015,70018,60019,70018,80018,30018,90021,20020,20023,70023,50029,90026,20047,10057,20052,40048,40015,80014,40020,00019,70016,70017,20031,10025,00026,80018,60025,50014,80017,40016,80050,80053,20051,90052,10000060,400
   > Long-term Assets 
0
0
0
0
1,898,900
1,892,000
1,858,000
1,853,300
1,842,700
1,833,300
1,832,400
1,340,300
1,324,200
1,313,100
1,502,300
1,489,400
1,478,300
1,472,000
1,470,100
1,467,900
1,035,200
1,041,800
1,040,900
1,107,300
1,119,800
1,174,000
1,210,900
1,261,200
1,261,100
1,239,600
1,238,800
1,231,500
1,205,600
1,200,900
1,239,800
1,192,900
1,176,000
1,327,300
1,315,700
1,305,200
1,287,100
1,281,100
1,159,800
1,200,300
1,205,400
1,193,500
1,183,700
1,183,600
1,183,6001,183,7001,193,5001,205,4001,200,3001,159,8001,281,1001,287,1001,305,2001,315,7001,327,3001,176,0001,192,9001,239,8001,200,9001,205,6001,231,5001,238,8001,239,6001,261,1001,261,2001,210,9001,174,0001,119,8001,107,3001,040,9001,041,8001,035,2001,467,9001,470,1001,472,0001,478,3001,489,4001,502,3001,313,1001,324,2001,340,3001,832,4001,833,3001,842,7001,853,3001,858,0001,892,0001,898,9000000
       Property Plant Equipment 
325,700
0
0
0
324,900
326,000
284,900
292,800
277,800
281,800
286,000
282,100
279,500
275,600
272,600
265,000
260,800
258,300
259,700
261,100
109,900
117,500
123,500
137,000
154,100
214,500
241,600
246,100
248,500
238,600
239,300
233,800
223,600
218,500
214,800
211,100
206,700
203,000
198,200
195,900
194,500
191,800
151,700
143,900
144,000
140,400
140,100
136,000
136,000140,100140,400144,000143,900151,700191,800194,500195,900198,200203,000206,700211,100214,800218,500223,600233,800239,300238,600248,500246,100241,600214,500154,100137,000123,500117,500109,900261,100259,700258,300260,800265,000272,600275,600279,500282,100286,000281,800277,800292,800284,900326,000324,900000325,700
       Goodwill 
1,434,100
0
0
0
1,430,100
1,430,800
1,432,800
1,429,000
1,426,100
1,422,100
1,422,800
943,400
945,200
946,800
1,031,600
1,031,900
1,029,000
1,029,700
1,030,900
1,032,000
764,700
764,600
763,800
786,700
783,600
783,700
782,300
800,500
800,900
799,800
800,200
801,200
802,500
802,100
802,600
801,800
801,600
826,000
825,000
823,600
819,400
821,500
762,600
791,500
796,100
794,900
794,400
795,100
795,100794,400794,900796,100791,500762,600821,500819,400823,600825,000826,000801,600801,800802,600802,100802,500801,200800,200799,800800,900800,500782,300783,700783,600786,700763,800764,600764,7001,032,0001,030,9001,029,7001,029,0001,031,9001,031,600946,800945,200943,4001,422,8001,422,1001,426,1001,429,0001,432,8001,430,8001,430,1000001,434,100
       Intangible Assets 
1,610,900
0
0
0
141,200
132,500
125,100
116,300
108,300
101,800
95,400
89,000
82,600
77,400
182,400
176,700
169,800
164,400
159,800
154,800
148,900
144,600
139,500
173,900
168,200
163,200
158,500
189,500
184,300
179,300
174,600
170,100
157,700
153,600
149,500
145,300
141,200
271,100
264,900
258,700
251,000
244,700
222,600
242,200
239,500
232,800
226,200
220,100
220,100226,200232,800239,500242,200222,600244,700251,000258,700264,900271,100141,200145,300149,500153,600157,700170,100174,600179,300184,300189,500158,500163,200168,200173,900139,500144,600148,900154,800159,800164,400169,800176,700182,40077,40082,60089,00095,400101,800108,300116,300125,100132,500141,2000001,610,900
       Long-term Assets Other 
0
0
0
0
2,700
2,700
15,200
15,200
30,500
27,600
28,200
25,800
2,000
2,000
3,700
3,600
3,600
3,800
3,600
3,700
4,100
3,800
3,500
3,400
7,600
6,400
15,200
12,800
11,300
10,900
10,700
14,400
11,800
11,300
11,000
11,100
16,500
15,900
16,500
16,100
17,600
18,600
18,500
18,400
19,300
19,100
16,700
25,800
25,80016,70019,10019,30018,40018,50018,60017,60016,10016,50015,90016,50011,10011,00011,30011,80014,40010,70010,90011,30012,80015,2006,4007,6003,4003,5003,8004,1003,7003,6003,8003,6003,6003,7002,0002,00025,80028,20027,60030,50015,20015,2002,7002,7000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
14,900
11,300
12,000
12,200
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000012,20012,00011,30014,900000000000000
> Total Liabilities 
478,500
0
0
0
404,900
359,900
379,000
370,400
1,036,400
1,024,600
963,700
965,300
944,900
939,900
1,022,500
993,500
969,300
955,500
968,100
968,200
980,500
951,100
630,800
544,300
536,200
553,900
506,500
540,800
534,400
507,200
494,300
509,200
416,300
396,200
387,000
336,000
330,700
510,000
501,200
511,700
495,700
436,200
431,900
502,800
456,100
433,400
435,800
426,500
426,500435,800433,400456,100502,800431,900436,200495,700511,700501,200510,000330,700336,000387,000396,200416,300509,200494,300507,200534,400540,800506,500553,900536,200544,300630,800951,100980,500968,200968,100955,500969,300993,5001,022,500939,900944,900965,300963,7001,024,6001,036,400370,400379,000359,900404,900000478,500
   > Total Current Liabilities 
359,100
0
0
0
310,400
265,300
283,800
277,900
356,000
341,000
324,000
326,800
315,200
309,300
304,900
310,700
324,400
310,000
321,800
319,400
389,800
360,600
352,800
265,500
264,300
238,400
187,000
218,100
212,500
189,400
176,000
179,400
166,300
154,600
158,300
129,200
139,200
152,900
151,100
162,300
185,800
158,500
160,500
170,700
234,600
205,200
208,200
212,900
212,900208,200205,200234,600170,700160,500158,500185,800162,300151,100152,900139,200129,200158,300154,600166,300179,400176,000189,400212,500218,100187,000238,400264,300265,500352,800360,600389,800319,400321,800310,000324,400310,700304,900309,300315,200326,800324,000341,000356,000277,900283,800265,300310,400000359,100
       Short-term Debt 
0
0
0
0
11,900
9,400
10,400
10,900
3,900
3,900
0
0
578,100
0
0
0
579,000
0
579,900
580,400
39,800
542,000
247,400
0
0
11,700
14,700
14,500
14,700
14,300
15,400
15,600
15,500
15,100
14,900
14,700
14,700
14,500
18,200
19,600
19,000
18,300
19,700
18,900
34,200
20,900
39,000
23,100
23,10039,00020,90034,20018,90019,70018,30019,00019,60018,20014,50014,70014,70014,90015,10015,50015,60015,40014,30014,70014,50014,70011,70000247,400542,00039,800580,400579,9000579,000000578,100003,9003,90010,90010,4009,40011,9000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
3,900
0
0
0
578,100
0
0
0
579,000
0
579,900
580,400
39,800
542,000
247,400
0
0
11,700
0
0
0
0
0
0
0
0
0
0
0
0
4,700
6,200
6,200
6,200
6,200
6,200
8,600
9,400
10,200
9,400
9,40010,2009,4008,6006,2006,2006,2006,2006,2004,70000000000000011,70000247,400542,00039,800580,400579,9000579,000000578,1000003,90000000000
       Accounts payable 
102,200
0
0
0
118,500
113,500
121,000
118,400
168,700
192,100
200,600
179,100
163,200
181,100
168,600
166,500
173,100
179,700
184,400
172,500
171,200
194,400
176,900
159,200
169,900
148,800
99,400
94,700
83,000
73,500
75,800
75,900
67,600
59,200
65,500
54,900
56,400
63,800
64,200
62,700
67,900
59,600
65,400
52,100
56,300
57,000
51,400
54,200
54,20051,40057,00056,30052,10065,40059,60067,90062,70064,20063,80056,40054,90065,50059,20067,60075,90075,80073,50083,00094,70099,400148,800169,900159,200176,900194,400171,200172,500184,400179,700173,100166,500168,600181,100163,200179,100200,600192,100168,700118,400121,000113,500118,500000102,200
       Other Current Liabilities 
160,300
0
0
0
167,800
131,200
140,500
142,600
181,300
121,200
123,400
147,700
152,000
128,200
136,300
144,200
151,300
130,300
137,400
146,900
33,900
166,200
175,900
106,300
94,400
11,700
68,700
105,100
111,600
98,300
80,400
85,900
80,500
76,900
75,900
57,800
68,100
74,600
68,700
80,000
98,900
80,600
2,700
2,500
127,400
92,300
111,700
129,400
129,400111,70092,300127,4002,5002,70080,60098,90080,00068,70074,60068,10057,80075,90076,90080,50085,90080,40098,300111,600105,10068,70011,70094,400106,300175,900166,20033,900146,900137,400130,300151,300144,200136,300128,200152,000147,700123,400121,200181,300142,600140,500131,200167,800000160,300
   > Long-term Liabilities 
0
0
0
0
94,500
94,600
95,200
92,500
680,400
683,600
639,700
638,500
629,700
630,600
717,600
682,800
644,900
645,500
646,300
648,800
590,700
590,500
278,000
278,800
271,900
315,500
319,500
322,700
321,900
317,800
318,300
329,800
250,000
241,600
228,700
206,800
191,500
357,100
350,100
349,400
309,900
277,700
271,400
332,100
221,500
228,200
227,600
213,600
213,600227,600228,200221,500332,100271,400277,700309,900349,400350,100357,100191,500206,800228,700241,600250,000329,800318,300317,800321,900322,700319,500315,500271,900278,800278,000590,500590,700648,800646,300645,500644,900682,800717,600630,600629,700638,500639,700683,600680,40092,50095,20094,60094,5000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
632,300
631,400
585,800
585,900
578,100
578,500
624,000
589,400
579,000
579,400
579,900
580,400
541,100
542,000
247,400
247,600
247,700
247,900
247,800
247,900
248,100
248,200
248,400
248,500
180,000
175,000
165,000
145,000
130,000
254,400
249,300
247,800
226,300
204,700
0
0
0
0
0
0
000000204,700226,300247,800249,300254,400130,000145,000165,000175,000180,000248,500248,400248,200248,100247,900247,800247,900247,700247,600247,400542,000541,100580,400579,900579,400579,000589,400624,000578,500578,100585,900585,800631,400632,30000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
-11,900
-9,400
-10,400
-10,900
-3,900
-3,900
0
0
-578,100
0
0
0
-579,000
0
-579,900
-580,400
-39,800
-542,000
-247,400
0
0
57,700
65,500
62,500
62,600
58,800
58,900
56,100
53,300
50,100
47,500
46,100
42,800
40,000
33,700
30,600
28,500
26,200
24,700
23,300
6,900
17,200
4,200
17,100
17,1004,20017,2006,90023,30024,70026,20028,50030,60033,70040,00042,80046,10047,50050,10053,30056,10058,90058,80062,60062,50065,50057,70000-247,400-542,000-39,800-580,400-579,9000-579,000000-578,10000-3,900-3,900-10,900-10,400-9,400-11,9000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
14,900
11,300
12,000
12,200
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000012,20012,00011,30014,900000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
48,100
0
0
0
27,800
28,200
30,200
30,000
30,100
29,900
30,000
31,900
31,800
30,200
29,600
30,100
19,800
63,200
71,100
74,300
73,800
69,600
69,900
67,500
64,300
61,000
4,900
56,200
51,900
68,000
23,500
64,600
18,700
15,500
15,400
15,600
4,100
4,100
3,900
3,900
3,9003,9004,1004,10015,60015,40015,50018,70064,60023,50068,00051,90056,2004,90061,00064,30067,50069,90069,60073,80074,30071,10063,20019,80030,10029,60030,20031,80031,90030,00029,90030,10030,00030,20028,20027,80000048,10000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
23,800
23,900
63,400
63,400
35,800
36,200
36,400
36,500
17,800
18,300
1,000
1,100
4,400
4,400
600
500
0
0
0
13,800
5,700
5,600
5,600
5,600
9,600
34,700
34,700
37,000
25,400
25,100
21,800
0
0
0
0
0
0000021,80025,10025,40037,00034,70034,7009,6005,6005,6005,6005,70013,8000005006004,4004,4001,1001,00018,30017,80036,50036,40036,20035,80063,40063,40023,90023,800000000000000
> Total Stockholder Equity
2,055,700
0
0
0
2,079,100
2,103,500
2,077,300
2,079,000
1,491,200
1,511,800
1,521,800
1,041,000
1,055,300
1,079,800
1,089,500
1,101,500
1,102,500
1,130,900
1,156,800
1,180,700
1,215,400
1,251,800
1,286,600
1,300,200
1,297,200
1,280,100
1,276,900
1,266,900
1,265,200
1,256,500
1,261,600
1,289,900
1,256,500
1,252,600
1,296,300
1,261,900
1,263,900
1,256,500
1,251,600
1,263,500
1,291,200
1,298,700
1,234,800
1,222,100
1,236,300
1,227,900
1,222,000
1,229,700
1,229,7001,222,0001,227,9001,236,3001,222,1001,234,8001,298,7001,291,2001,263,5001,251,6001,256,5001,263,9001,261,9001,296,3001,252,6001,256,5001,289,9001,261,6001,256,5001,265,2001,266,9001,276,9001,280,1001,297,2001,300,2001,286,6001,251,8001,215,4001,180,7001,156,8001,130,9001,102,5001,101,5001,089,5001,079,8001,055,3001,041,0001,521,8001,511,8001,491,2002,079,0002,077,3002,103,5002,079,1000002,055,700
   Common Stock
0
0
0
0
0
0
0
0
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
50050050050050050050050050050050050050050050050050050050050050050050050050050050050050050050050050050050050050050050050000000000
   Retained Earnings Total Equity
0
0
0
0
0
0
0
0
7,300
29,000
36,900
-433,600
-419,000
-404,800
-398,300
-389,200
-379,200
-366,400
-349,300
-332,700
-299,900
-279,700
-244,400
-240,200
-242,400
-262,700
-270,700
-282,200
-288,300
-284,600
-287,600
-268,300
-315,500
-323,100
-285,200
-320,300
-310,300
-304,500
-293,100
-270,000
-253,100
-253,600
-321,700
0
0
0
0
0
00000-321,700-253,600-253,100-270,000-293,100-304,500-310,300-320,300-285,200-323,100-315,500-268,300-287,600-284,600-288,300-282,200-270,700-262,700-242,400-240,200-244,400-279,700-299,900-332,700-349,300-366,400-379,200-389,200-398,300-404,800-419,000-433,60036,90029,0007,30000000000
   Accumulated Other Comprehensive Income -36,900-37,500-29,500-27,000-33,000-28,400-35,800-35,800-42,900-37,800-32,100-33,800-33,600-30,000-32,300-28,100-37,100-42,000-46,900-32,000-34,800-31,100-33,000-33,700-30,500-32,100-21,800-31,300-30,600-34,300-39,400-50,100-38,300-38,100-36,600-43,200-42,800-28,900-25,600-19,100-21,100-11,600-14,600-19,6000000
   Capital Surplus 
0
0
0
0
0
0
0
0
1,502,500
1,507,900
1,514,300
1,517,900
1,518,000
1,521,700
1,527,300
1,530,400
1,533,200
1,538,100
1,543,800
1,547,400
1,550,500
1,557,300
1,567,700
1,575,500
1,578,100
1,582,500
1,586,800
1,592,100
1,593,900
1,596,400
1,599,900
1,604,100
1,609,400
1,617,300
1,621,300
1,625,700
1,628,800
1,633,300
1,637,400
1,642,300
1,646,400
1,651,000
1,654,900
0
0
0
0
0
000001,654,9001,651,0001,646,4001,642,3001,637,4001,633,3001,628,8001,625,7001,621,3001,617,3001,609,4001,604,1001,599,9001,596,4001,593,9001,592,1001,586,8001,582,5001,578,1001,575,5001,567,7001,557,3001,550,5001,547,4001,543,8001,538,1001,533,2001,530,4001,527,3001,521,7001,518,0001,517,9001,514,3001,507,9001,502,50000000000
   Treasury Stock0000000000-40,700-21,300-10,400-10,300-9,800-9,800-9,300-9,200-8,900-8,900-8,700-8,600-7,200-5,300-5,100-5,100-4,500-4,400-3,900-3,900-1,900-1,900-1,900-1,900-1,000-1,000-1,000-1,0000000000000
   Other Stockholders Equity 
0
0
0
0
2,098,700
2,118,100
2,088,900
2,100,100
1,502,500
1,507,900
1,513,300
1,516,900
1,517,000
1,520,700
1,525,400
1,528,500
1,531,300
1,536,200
1,539,900
1,543,500
1,546,100
1,552,800
1,562,600
1,570,400
1,572,800
1,575,300
1,578,200
1,583,400
1,585,000
1,587,500
1,590,700
1,594,800
1,599,600
1,607,500
1,611,000
1,615,300
1,607,500
1,592,600
1,582,000
1,575,900
1,579,600
1,587,100
1,584,400
1,580,000
1,577,700
1,572,700
1,573,000
1,575,800
1,575,8001,573,0001,572,7001,577,7001,580,0001,584,4001,587,1001,579,6001,575,9001,582,0001,592,6001,607,5001,615,3001,611,0001,607,5001,599,6001,594,8001,590,7001,587,5001,585,0001,583,4001,578,2001,575,3001,572,8001,570,4001,562,6001,552,8001,546,1001,543,5001,539,9001,536,2001,531,3001,528,5001,525,4001,520,7001,517,0001,516,9001,513,3001,507,9001,502,5002,100,1002,088,9002,118,1002,098,7000000



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.